Banqladesh Drug Policy
Executive Summary
Monograph on "Public Health and Economic Dimensions of the New Drug Policy of Bangladesh" published by PMA. The monograph was written by Sri Lankan attorney, D.C. Jayasuriya. In a personal communication with govt. officials cited in the monograph, Jayasuriya estimates that Bangladesh's foreign currency expenditures on drug raw materials may have increased 40% between 1982 and 1983 as a result of the effort to increase local manufacturing.
You may also be interested in...
US FDA And NIST Form Partnership To Boost Advanced Manufacturing Techniques
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
Medtronic Looks To Adaptive DBS To Advance Treatment Of Parkinson’s Disease
Medtronic is sponsoring a trial to evaluate its adaptive deep brain stimulation technology, a unique feature of the Percept PC device for treating Parkinson’s disease.
Merck & Co. Pivots To COVID-19 Treatments After Vaccines Disappoint
The company cited lackluster efficacy in its decision to discontinue development of V590 and V591. It will instead develop two drugs to treat COVID-19.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: